The clinical behavior of localized and multicentric Castleman disease

Annals of Internal Medicine

Volumn 128, Issue 8, 1998, Pages 657-662

  Herrada, Juan ^a,b   Cabanillas, Fernando ^a   Rice, Lawrence ^a,c   Manning, John ^a   Pugh, William ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b El Paso Cancer Treatment Center   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; FEMALE; HUMAN; INFECTION; MALE; MORTALITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REMISSION; REVIEW; TREATMENT OUTCOME;

EID: 0032522697     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-128-8-199804150-00010     Document Type: Review

References (7)

1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia. Cancer. 1956;9:822-30.
2. Flendrig JA, Schillings PM. Benign giant lymphoma: the clinical signs and symptoms. Folia Medica Neerlandica. 1969;12:119-20.
3. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670-83.
4. Frizzera G. Atypical lymphoproliferative disorders. In: Knowles DM, ed. Neoplastic Hematopathology. Baltimore. MD: Williams & Wilkins; 1992:454-95.
5. Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol. 1988;5:346-64.
6. Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol. 1978;69:86-90.
7. Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol. 1985;3:1202-16.